First equity-risk transaction under InnovFin: EUR 25 million to support Innocoll’s pharmaceutical R&D activities
The European Investment Bank (EIB) has signed a EUR 25 million loan with Innocoll AG. This is the first equity-risk transaction supported by “InnovFin – EU Finance for Innovators”, a new generation of financial products fostering R&D in Europe.
Innocoll specialises in the development and manufacturing of new pharmaceutical drugs and medical devices using its proprietary collagen technology. The company’s lead products, which are either already approved or in the last stages of development, focus on post-surgical pain relief, the treatment of diabetic foot infections and post-surgical adhesions. The EIB financing will support the development of these novel products, as well as the expansion of Innocoll’s manufacturing facility near Munich, Germany.
Innocoll’s R&D project is supported by “InnovFin – EU Finance for Innovators” MidCap Growth Finance, with the financial backing of the European Union under Horizon 2020 Financial Instruments. InnovFin is a new range of EIB Group products designed to facilitate access to finance for innovative businesses. InnovFin MidCap Growth Finance offers long-term senior, subordinated or mezzanine loans from EUR 7.5 to 25 million for innovative larger midcaps (up to 3000 employees), but also SMEs and small midcaps.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.